Beta Bionics Capital Raise of $150M
Beta Bionics, Inc. priced a public offering of 7,652,175 shares of common stock and pre-funded warrants for gross proceeds of approximately $150.0 million. The offering was priced at $17.25 per share, and the company granted underwriters a 30-day option to purchase up to an additional 1,304,348 shares. Proceeds are intended for general corporate purposes, including the commercialization of its Mint product and manufacturing facility expansion.
- Value
- $150M
- Counterparty
- J.P. Morgan Securities LLC, Piper Sandler & Co., Wells Fargo Securities, LLC and Leerink Partners LLC